What does Benztropine do?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benztropine: Mechanism and Clinical Applications

Benztropine is an anticholinergic medication primarily used to treat extrapyramidal symptoms caused by antipsychotic medications, with a secondary role in managing Parkinson's disease symptoms. 1

Pharmacological Mechanism

Benztropine works through two primary mechanisms:

  • Anticholinergic activity: Blocks muscarinic acetylcholine receptors with potency approximately half that of atropine when administered orally. This is the therapeutically significant mechanism for managing parkinsonism and drug-induced extrapyramidal symptoms. 1

  • Antihistaminic effects: Possesses antihistaminic properties similar to pyrilamine maleate, though this action is less clinically significant for its primary indications. 1

Primary Clinical Applications

1. Management of Antipsychotic-Induced Extrapyramidal Symptoms (EPS)

Benztropine is commonly used to treat:

  • Drug-induced parkinsonism
  • Acute dystonic reactions
  • Akathisia

However, it should be used with caution as guidelines recommend:

  • Avoiding benztropine when possible due to significant anticholinergic side effects 2
  • Using it only for problematic extrapyramidal symptoms that cannot be managed by other means 2

2. Adjunctive Treatment in Parkinson's Disease

Benztropine can help manage:

  • Tremor
  • Rigidity
  • Bradykinesia

Important Clinical Considerations

Medication Combinations

Benztropine is often used in combination therapy:

  • As part of a medication combination to address side effects of an effective agent (specifically for extrapyramidal symptoms secondary to antipsychotics) 2

Contraindications and Cautions

  1. Avoid in elderly patients with dementia: Can worsen cognitive function and cause delirium 3

  2. Risk of anticholinergic toxicity: Can cause serious adverse effects including:

    • Delirium and psychosis 3
    • Stereotyped movements 3
    • Potentially fatal toxicity in overdose 4
  3. Withdrawal concerns: Abrupt discontinuation may lead to withdrawal-emergent dyskinesia 5

Adverse Effects

Common adverse effects include:

  • Dry mouth
  • Blurred vision
  • Constipation
  • Urinary retention
  • Cognitive impairment
  • Confusion
  • Hallucinations

Severe cases can present with:

  • Delirium 3
  • Stereotyped movements 3
  • Mania or hypomania (dose-related) 6

Clinical Pearls

  1. Dosing considerations: Start with low doses and titrate carefully, especially in elderly patients

  2. Monitoring: Watch for signs of anticholinergic toxicity including confusion, hallucinations, and urinary retention

  3. Discontinuation: Taper gradually rather than stopping abruptly to avoid withdrawal-emergent dyskinesia 5

  4. Alternative options: Consider atypical antipsychotics with lower EPS risk when possible, rather than adding benztropine to high-risk antipsychotics 2

  5. Mood effects: At very low doses (0.25 mg daily), benztropine may have mood-elevating effects in some patients with Parkinson's disease and depression 6

Comparison with Other Anticholinergics

Some evidence suggests that benztropine may have more central nervous system side effects compared to other anticholinergics:

  • Patients treated with benztropine showed more anxiety and depression compared to those treated with ethopropazine 7
  • Benztropine treatment was associated with increased tardive dyskinesia compared to procyclidine 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Delirium and stereotypy from anticholinergic antiparkinson drugs.

Progress in neuro-psychopharmacology & biological psychiatry, 1982

Research

Fatal benztropine toxicity.

Medicine, science, and the law, 2001

Research

Withdrawal-Emergent Dyskinesia Related to Benztropine: A Case Report.

WMJ : official publication of the State Medical Society of Wisconsin, 2023

Research

Anticholinergic effects in a depressed parkinsonian patient.

Journal of geriatric psychiatry and neurology, 1995

Research

Ethopropazine and benztropine in neuroleptic-induced parkinsonism.

The Journal of clinical psychiatry, 1979

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.